Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

SQSTM1 gene issues may increase the risk of alopecia areata.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

The system can have a stable solution under certain conditions, helping understand hair loss in Alopecia Areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

The lotion helps manage mild to moderate hair loss.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

Recognizing congenital triangular alopecia is crucial to avoid unnecessary treatments.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

A rare skin cancer caused hair loss and spread, needing multiple treatments.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

A woman's hair loss and skin discoloration were found to be caused by a rare case of leprosy on the scalp, not alopecia-vitiligo overlap.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A rare case of hair loss was linked to breast cancer spreading to the scalp, but treatment was effective.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

Vitamin D levels do not affect the risk of developing alopecia areata.

A 4-year-old boy with a rare type of rickets and hair loss improved in bone health but not hair growth after vitamin D and calcium treatment.

Cases of alopecia areata and its impact on life quality rose globally, but when adjusted for age, the rates decreased, especially in poorer regions.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Long working hours increase the risk of hair loss in Korean male workers.

Recognizing the link between certain autoimmune disorders and neurological conditions can improve diagnosis and treatment.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Men with hair loss are more likely to experience moderate to severe COVID-19 symptoms.

A young man was diagnosed with trichoepitheliomas, causing thick skin and hair loss.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

A 2-year-old girl with a rare vitamin D disorder had rickets and hair loss, but treatment was ineffective due to poor compliance.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.